Highly Active Antiretroviral Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

LAAM-HAART PET Imaging
Condition:   Healthy VolunteersInterventions:   Radiation: [11c] LAAM;   Drug: Ritonavir;   Drug: EfavirenzSponsor:   Washington University School of MedicineRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2013 Category: Research Source Type: clinical trials

LAAM-HAART PET Imaging
Condition:   Healthy VolunteersInterventions:   Radiation: [11c] LAAM;   Drug: Ritonavir;   Drug: EfavirenzSponsor:   Washington University School of MedicineRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2013 Category: Research Source Type: clinical trials

LAAM-HAART PET Imaging
Condition:   Healthy VolunteersInterventions:   Radiation: [11c] LAAM;   Drug: Ritonavir;   Drug: EfavirenzSponsor:   Washington University School of MedicineRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2013 Category: Research Source Type: clinical trials

LAAM-HAART PET Imaging
Condition:   Healthy VolunteersInterventions:   Radiation: [11c] LAAM;   Drug: Ritonavir;   Drug: EfavirenzSponsor:   Washington University School of MedicineActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2013 Category: Research Source Type: clinical trials

LAAM-HAART PET Imaging
Condition:   Healthy VolunteersInterventions:   Radiation: [11c] LAAM;   Drug: Ritonavir;   Drug: EfavirenzSponsor:   Washington University School of MedicineRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2013 Category: Research Source Type: clinical trials

An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Conditions:   HIV Infection;   PregnancyIntervention:   Other: Tokafatso programmatic interventionSponsors:   Harvard School of Public Health;   Harvard School of Public Health;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Completed - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2013 Category: Research Source Type: clinical trials

DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition:   Human Immunodeficiency VirusInterventions:   Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.Sponsors:   Ospedale L. Sacco – Polo Universitario;   Elisa Colella, M.D.;   Valentina Di Cristo, M.D.;   Massimo Galli, M.D.Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2013 Category: Research Source Type: clinical trials